More importantly, silencing of YBX1 reversed the protective effect of lncKCND1, suggesting that YBX1 is a downstream target in the machinery of lncKCND1 regulation of cardiac hypertrophy [45]. The gene discussed is YBX1; the disease is cardiac hypertrophy.